RecallRadar

FDA Device recall Z-0323-2018

Alaris PCA Pump, Model 8120

On 2018-01-17 the FDA classified a Class II recall of Alaris PCA Pump, Model 8120 by Carefusion 303, citing the syringe plunger grippers may fail to automatically close around the syringe plunger press when the gripper control knob has been closed.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0323-2018
ClassificationClass II
Statusterminated
Initiated2017-11-17
Published2018-01-17
Last updated2026-09-13 11:54 UTC
CompanyCarefusion 303
DistributionUS

Product

Alaris PCA Pump, Model 8120. The firm name on the label is CareFusion. The Alaris Syringe Pump module and Alaris PCA module are infusion pump modules for the Alaris System. The syringe pump and PCA pump delivers medication or fluids in a manner similar to current syringe pumps on the market. The modules are indicated for use on adults, pediatrics and neonates for continuous or intermittent delivery through clinically acceptable routes of administration such as intravenous, subcutaneous or epidural. The Alaris Syringe pump and PCA modules can be connected to the Alaris PC unit which is the central programming, monitoring, and power supply component for the Alaris System. The syringe pump and PCA pump uses standard, plastic piston syringes and single-use administration sets with luer-lock connectors.

Reason

The syringe plunger grippers may fail to automatically close around the syringe plunger press when the gripper control knob has been closed.

Identifiers

code_infoUDI 10885403812002. Product involved are those devices manufactured and/or serviced between 5/1/2013 through 4/30/2017.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0323-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.